Email updates

Keep up to date with the latest news and content from Microbial Cell Factories and BioMed Central.

Open Access Highly Accessed Commentary

Towards universal systems for recombinant gene expression

Hans Peter Sørensen

Author Affiliations

Danish-Chinese Centre for Proteases and Cancer, Danish National Research Foundation, Aarhus University, Department of Molecular Biology, Gustav Wieds Vej 10C, DK 8000 Aarhus, Denmark

Microbial Cell Factories 2010, 9:27  doi:10.1186/1475-2859-9-27


The electronic version of this article is the complete one and can be found online at: http://www.microbialcellfactories.com/content/9/1/27


Received:15 April 2010
Accepted:30 April 2010
Published:30 April 2010

© 2010 Sørensen; licensee BioMed Central Ltd.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Recombinant gene expression is among the most important techniques used both in molecular and medical research and in industrial settings. Today, two recombinant expression systems are particularly well represented in the literature reporting on recombinant expression of specific genes. According to searches in the PubMed citation database, during the last 15 years 80% of all recombinant genes reported on in the literature were expressed in either the enterobacterium Escherichia coli or the methylotropic yeast Pichia pastoris. Nevertheless, some eukaryotic proteins are misfolded or inadequately posttranslationally modified in these expression systems. This situation demands identification of other recombinant expression systems that enable the proper expression of the remaining eukaryotic genes. As of now, a single universal system allowing expression of all target genes is still a distant goal. In this light, thorough experimental screening for systems that can yield satisfying quantity and quality of target protein is required. In recent years, a number of new expression systems have been described and used for protein production. Two systems, namely Drosophila melanogaster S2 insect cells and human embryonic kidney 293 (HEK293) cells stably expressing the EBNA-1 gene, show exceptional promise. The time has come to identify a few well-performing systems that will allow us to express, purify, and characterize entire eukaryotic genomes.

Introduction

Escherichia coli was the first host to be used for recombinant gene expression almost 40 years ago [1]. Within the past 15 years, Pichia pastoris has successfully entered the scene and is now the second most-used host for recombinant gene expression. Based on searches of the PubMed citation database, the use of P. pastoris as an expression host has increased from 4% to 17% of the total recombinant genes reported on from 1995 to 2009 (Fig. 1). Within the same time period, the usage of E. coli as an expression host remained constant, with approximately 60% of the recombinant genes reported on in journals indexed in PubMed being expressed in E. coli. Similar trends prevailed when analyzing publications in the journal Microbial Cell Factories during the period from 2005 to 2009 (Fig. 1). Several other expression systems are widely used, but to a lesser extent than E. coli and P. pastoris. So, why are E. coli and P. pastoris particularly suited for recombinant gene expression?

thumbnailFigure 1. Percentage of all proteins reported to be produced in E. coli or P. pastoris recombinant gene expression systems based on literature searches. The PubMed citation database http://www.ncbi.nlm.nih.gov/pubmed/ webcite or the journal Microbial Cell Factories http://http://www.microbialcellfactories.com/ webcite was searched using "recombinant protein" only or in combination with "Escherichia coli" or "Pichia pastoris" as a keyword. Data represent the percent of total citations found by searching using "recombinant protein" that was found when that term was combined with one of the two organism names. Citation data are presented for the last 15 years for PubMed and the last 5 years for Microbial Cell Factories.

Protein produced from a recombinant gene in E. coli as a soluble and functional product with high yield is the ideal situation for most research and industrial protein production purposes [2-4]. However, this situation is far from realistic for all recombinant gene products. In particular, proteins derived from eukaryotes are prone to inclusion body formation and low yields. This outcome can be explained by the fact that the rate of gene translation in E. coli is 4- to 10-fold higher than in eukaryotes [5]. Correct formation of disulfide bonds, protein folding, and protein function must be carefully assessed both when the proteins have been recombinantly produced in E. coli in a soluble form, when they have been refolded in vitro, or obtained from any other source [6]. Further, E. coli should not be used as the expression system if posttranslational modifications (PTMs) are of importance for the study or purpose of the protein because these microbes are unable to incorporate PTMs, including N-linked glycan chains. However, when it is able to both properly form and posttranslationally modify a protein, E. coli is the perfect expression host, allowing fast and inexpensive preparation of heterologous proteins.

Many of the advantageous properties of E. coli are also offered by P. pastoris, a methylotropic yeast that can exploit methanol as its only carbon source [7,8]. As compared with E. coli, P. pastoris folds most eukaryotic proteins more efficiently and forms disulfide bonds correctly. Cultivation of P. pastoris in methanol-containing medium results in strong upregulation of the promoter of the alcohol oxidase I (AOX1) gene. This strong and tightly regulated promoter is therefore incorporated into the majority of vectors for expression of recombinant genes in P. pastoris [9]. When using P. pastoris, the recombinant gene product is typically engineered with a signal sequence to facilitate secretion, and the vectors used are selected to integrate into the genome [9]. However, the N-linked glycan chains added posttranslationally to proteins produced in P. pastoris are substantially different from the modifications added by mammalian cells [10].

Discussion

Given that we have these two excellent systems that together over the last 15 years have been used to express up to 80% of all reported recombinant genes, what else is still needed? Imagine setting up a laboratory working to express recombinant eukaryotic genes for biochemical and structural analysis. Which recombinant expression systems need to be implemented? Numerous important factors must be considered before expression of a recombinant gene is attempted. What is the mass of the polypeptide? Multi domain proteins are typically more difficult to produce than the alternative single domain deletion mutants. Does the protein contain any disulfide bonds? Proteins with disulfide bonds would most likely not be correctly folded in E. coli [11]. Are any PTMs required for protein folding, stability, or function, and what is the final destination of the protein--secreted, in the cytoplasm, or incorporated into the membrane?

Based on published studies, E. coli and P. pastoris enable the expression of most recombinant genes. However, one or two alternative methods would be required to fill the final gap and enable expression of genes that could not be expressed in either E. coli or P. pastoris. Here, fast and relatively inexpensive expression systems are required. What properties that are unsatisfied by E. coli and P. pastoris are required by these systems? First, alternative expression systems should be able to correctly fold the proteins that require incorporation of PTMs, including glycan chains. Second, an alternative system should simply enable protein production at a decent yield when E. coli and P. pastoris expression systems fail. The choice of expression system is also highly dependent on the type of target protein (soluble, membrane bound, multi domain, containing disulfide bonds, etc.), as well as the intended use of the product. Proteins produced by recombinant methods are typically used in structural studies, in vitro activity assays, as antigens for antibodies, for in vivo studies, and as drugs or as targets for generating drugs. These different applications have different requirements for both quantity and quality.

Several important expression systems in addition to E. coli and P. pastoris have been described. The most prominent are insect cell expression systems, yeasts other than P. pastoris, mammalian cell lines, and a few prokaryotes other than E. coli (e.g., Bacillus subtilis) [12]. Are any of these expression systems significantly more successful than E. coli or P. pastoris, thereby representing an alternative to those two systems? Focusing on recombinant genes of eukaryotic origin, two systems deserve special attention. First, the insect cell line Drosophila melanogaster Schneider 2 (S2) has been increasingly utilized over the past few years for the production of heterologous proteins. This system takes advantage of stable integration of up to 1,000 target gene copies following transient transfection and antibiotic selection procedures. D. melanogaster S2 cells are cultivated at 28°C without any special requirements and yield appropriately processed and biologically active proteins [13,14]. Second, transiently transfected mammalian cell lines cultivated in suspension cultures under serum-free conditions are a promising candidate. Large-scale transfection of mammalian cells has gained increasing interest because of it-can quickly and inexpensively produce proteins [15]. In fact, such processes allows for milligram to gram amounts of protein to be produced in a short period of time (2-3 weeks). Several reports support the use of polyethylenimines for the transfection of human embryonic kidney 293 cells stably expressing the EBNA-1 gene (e.g., HEK293 6E) [15,16]. These cells are potentially suited for use in high-throughput recombinant gene expression facilities because of the fast and easy transient transfection procedure [17].

The use of screening of several expression systems would significantly improve the hit-rate for obtaining correctly folded, biologically active protein in high yield. High-throughput screening facilities for recombinant gene expression should at a minimum assess the expression of a target gene in E. coli and 2-3 eukaryotic expression systems. A laboratory with the ability to test expression of recombinant genes in E. coli, P. pastoris, Drosophila S2, and HEK293 EBNA systems would be perfectly equipped to successfully express most recombinant target genes.

Why do we need several hosts for recombinant gene expression? In the perfect scenario, one universal expression system would enable expression of all possible recombinant genes in a fast, inexpensive, and proper manner with respect to yield, folding, and biological activity. However, because of the limitations of existing systems, we are still far from that goal. It is therefore necessary to carefully evaluate the properties of every new target and to experimentally screen the most promising expression hosts.

Conclusions

Because 80% of all reported recombinant genes are expressed in either E. coli or P. pastoris, a modern research laboratory would be well equipped for recombinant gene expression by implementing these two systems. However, E. coli and P. pastoris are inadequate particularly for expression of many eukaryotic genes. Alternative systems useful for expression of eukaryotic genes have been described, but are less frequently used. Here I suggest the D. melanogaster S2 and HEK293 EBNA-1 expression systems as the most promising alternatives to E. coli or P. pastoris. We are still far from the "one-host-for-all-recombinant-gene-expression" era, and the most suitable system for a particular target protein should be determined empirically among qualified candidates.

List of abbreviations

HEK293: human embryonic kidney 293; PTM: posttranslational modification; S2: D. melanogaster Schneider 2 insect cell line

Competing interests

The authors declare that they have no competing interests.

Acknowledgements

This work was supported by the Danish National Research Foundation (Grant number: 26-331-6).

References

  1. Cohen SN, Chang AC, Boyer HW, Helling RB: Construction of biologically functional bacterial plasmids in vitro.

    Proc Natl Acad Sci USA 1973, 70(11):3240-3244. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  2. Baneyx F: Recombinant protein expression in Escherichia coli.

    Curr Opin Biotechnol 1999, 10(5):411-421. PubMed Abstract | Publisher Full Text OpenURL

  3. Sørensen HP, Mortensen KK: Soluble expression of recombinant proteins in the cytoplasm of Escherichia coli.

    Microb Cell Fact 2005, 4(1):1. PubMed Abstract | BioMed Central Full Text | PubMed Central Full Text OpenURL

  4. Sørensen HP, Mortensen KK: Advanced genetic strategies for recombinant protein expression in Escherichia coli.

    J Biotechnol 2005, 115(2):113-128. PubMed Abstract | Publisher Full Text OpenURL

  5. Widmann M, Christen P: Comparison of folding rates of homologous prokaryotic and eukaryotic proteins.

    J Biol Chem 2000, 275(25):18619-18622. PubMed Abstract | Publisher Full Text OpenURL

  6. de Marco A: Minimal information: an urgent need to assess the functional reliability of recombinant proteins used in biological experiments.

    Microb Cell Fact 2008, 7:20. PubMed Abstract | BioMed Central Full Text | PubMed Central Full Text OpenURL

  7. Cregg JM: Introduction: distinctions between Pichia pastoris and other expression systems.

    Methods Mol Biol 2007, 389:1-10. PubMed Abstract | Publisher Full Text OpenURL

  8. Holmes WJ, Darby RA, Wilks MD, Smith R, Bill RM: Developing a scalable model of recombinant protein yield from Pichia pastoris : the influence of culture conditions, biomass and induction regime.

    Microb Cell Fact 2009, 8:35. PubMed Abstract | BioMed Central Full Text | PubMed Central Full Text OpenURL

  9. Daly R, Hearn MT: Expression of heterologous proteins in Pichia pastoris : a useful experimental tool in protein engineering andproduction.

    J Mol Recognit 2005, 18(2):119-138. PubMed Abstract | Publisher Full Text OpenURL

  10. Celik E, Calik P, Halloran SM, Oliver SG: Production of recombinant human erythropoietin from Pichia pastoris and its structural analysis.

    J Appl Microbiol 2007, 103(6):2084-2094. PubMed Abstract | Publisher Full Text OpenURL

  11. de Marco A: Strategies for successful recombinant expression of disulfide bond-dependent proteins in Escherichia coli.

    Microb Cell Fact 2009, 8:26. PubMed Abstract | BioMed Central Full Text | PubMed Central Full Text OpenURL

  12. Zweers JC, Barak I, Becher D, Driessen AJ, Hecker M, Kontinen VP, Saller MJ, Vavrova L, van Dijl JM: Towards the development of Bacillus subtilis as a cell factory for membrane proteins and proteincomplexes.

    Microb Cell Fact 2008, 7:10. PubMed Abstract | BioMed Central Full Text | PubMed Central Full Text OpenURL

  13. Gardsvoll H, Hansen LV, Jorgensen TJ, Ploug M: A new tagging system for production of recombinant proteins in Drosophila S2 cells using the third domain of the urokinase receptor.

    Protein Expr Purif 2007, 52(2):384-394. PubMed Abstract | Publisher Full Text OpenURL

  14. Santos MG, Jorge SA, Brillet K, Pereira CA: Improving heterologous protein expression in transfected Drosophila S2 cells as assessed by EGFP expression.

    Cytotechnology 2007, 54(1):15-24. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  15. Baldi L, Muller N, Picasso S, Jacquet R, Girard P, Thanh HP, Derow E, Wurm FM: Transient gene expression in suspension HEK-293 cells: application to large-scale protein production.

    Biotechnol Prog 2005, 21(1):148-153. PubMed Abstract | Publisher Full Text OpenURL

  16. Carpentier E, Paris S, Kamen AA, Durocher Y: Limiting factors governing protein expression following polyethylenimine-mediated gene transfer in HEK293-EBNA1 cells.

    J Biotechnol 2007, 128(2):268-280. PubMed Abstract | Publisher Full Text OpenURL

  17. Chapple SD, Crofts AM, Shadbolt SP, McCafferty J, Dyson MR: Multiplexed expression and screening for recombinant protein production in mammalian cells.

    BMC Biotechnol 2006, 6:49. PubMed Abstract | BioMed Central Full Text | PubMed Central Full Text OpenURL